Health
Targeted treatments for EGFR-positive lung cancer can improve outcomes – Medical News Today
Targeted therapies are available for people with EGFR mutations, and they tend to be more effective. Learn more about the treatment…
EGFR mutations account for about 1015% of lung cancer cases in the United States. Biomarker testing allows oncologists to choose targeted treatments for these types of lung cancer.
Non-small cell lung cancer (NSCLC) accounts for about 85%
of lung cancer…
-
Noosa News22 hours agoBrisbane vs Collingwood live blog: Richmond selects Noah Balta as unbeaten Lions prepare for Magpies test
-
General21 hours agoNT Coalition candidate Lisa Siebert diverges from Jacinta Nampijinpa Price on royal commission call
-
General23 hours agoCanberra man named as doctor accused of rape after suppression order lifted
-
Noosa News22 hours agoMelbourne Market vendors say new rent offer too expensive as eviction threat looms